Erste Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-120,000
| Closed | -$1.24M | – | 655 |
|
|
2024
Q3 | $1.24M | Hold |
120,000
| – | – | 0.01% | 368 |
|
|
2024
Q2 | $1.56M | Hold |
120,000
| – | – | 0.02% | 334 |
|
|
2024
Q1 | $2.1M | Hold |
120,000
| – | – | 0.03% | 298 |
|
|
2023
Q4 | $1.13M | Buy |
120,000
+25,500
| +27% | +$240K | 0.02% | 365 |
|
|
2023
Q3 | $1.06M | Hold |
94,500
| – | – | 0.02% | 341 |
|
|
2023
Q2 | $2.01M | Hold |
94,500
| – | – | 0.04% | 288 |
|
|
2023
Q1 | $3.79M | Hold |
94,500
| – | – | 0.07% | 241 |
|
|
2022
Q4 | $4.4M | Buy |
94,500
+20,000
| +27% | +$932K | 0.09% | 218 |
|
|
2022
Q3 | $3.88M | Hold |
74,500
| – | – | 0.09% | 228 |
|
|
2022
Q2 | $3.51M | Hold |
74,500
| – | – | 0.08% | 242 |
|
|
2022
Q1 | $5.25M | Buy |
+74,500
| New | +$5.25M | 0.1% | 212 |
|
|
2020
Q4 | – | Sell |
-6,200
| Closed | -$278K | – | 615 |
|
|
2020
Q3 | $278K | Hold |
6,200
| – | – | 0.01% | 378 |
|
|
2020
Q2 | $304K | Hold |
6,200
| – | – | 0.01% | 364 |
|
|
2020
Q1 | $314K | Hold |
6,200
| – | – | 0.02% | 331 |
|
|
2019
Q4 | $388K | Hold |
6,200
| – | – | 0.02% | 338 |
|
|
2019
Q3 | $374K | Hold |
6,200
| – | – | 0.02% | 339 |
|
|
2019
Q2 | $520K | Hold |
6,200
| – | – | 0.03% | 315 |
|
|
2019
Q1 | $591K | Buy |
+6,200
| New | +$591K | 0.03% | 298 |
|